"Southern Neurology is a group neurology practice providing a comprehensive clinical neurology and neurophysiology service in southern Sydney"

During the past decade, Southern Neurology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Neurology" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "AstraZeneca" with 2 trials sponsored, "TauRx Therapeutics Ltd" with 2 trials sponsored, "Debiopharm International SA" with 1 trials sponsored and "ElectroCore INC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Neurology" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Southern Neurology" are "Alzheimer's Disease" (5 trials), "Alzheimer Disease" (2 trials), "Alzheimer´s Disease" (1 trials), "Behavioral Variant Frontotemporal Dementia" (1 trials) and "Moderate Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Southern Neurology" in a lesser frequency.

Most popular intervention types in "Southern Neurology" are "Drug" (9 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Donepezil" (2 trials), "Gantenerumab" (2 trials), "Lanabecestat" (2 trials) and "Galantamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Neurology" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Southern Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Southern Neurology, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Neurology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".